ArticleNeuro-oncology advances

Correction to: Effect of bevacizumab on refractory meningiomas: 3D volumetric growth rate versus response assessment in neuro-oncology criteria.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.